BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12928675)

  • 1. Malignant status at surgical margin of limited-resected non-small cell lung cancer: a crucial finding for predicting local relapse.
    Sawabata N
    J Thorac Cardiovasc Surg; 2003 Aug; 126(2):610-1; author reply 611. PubMed ID: 12928675
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of recurrence after complete resection in patients with NSCLC.
    Uramoto H; Tanaka F
    Anticancer Res; 2012 Sep; 32(9):3953-60. PubMed ID: 22993343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph nod involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas.
    Ginsberg RJ
    J Thorac Cardiovasc Surg; 1996 Jun; 111(6):1123-4. PubMed ID: 8642811
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor relapse after thoracic surgery?
    Garcia ME; Tomasini P; Thomas P; Greillier L; Barlesi F
    J Thorac Oncol; 2015 Feb; 10(2):397-8. PubMed ID: 25611231
    [No Abstract]   [Full Text] [Related]  

  • 5. Thoracic wall prosthesis prevents deep invasion by non-small-cell lung cancer.
    Mentens Y; Schrijvers D; Van den Brande J; Van Schil P; Vermorken JB
    Am J Clin Oncol; 2000 Feb; 23(1):32-3. PubMed ID: 10683071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytologically malignant margins of wedge resected stage I non-small cell lung cancer.
    Sawabata N; Matsumura A; Ohota M; Maeda H; Hirano H; Nakagawa K; Matsuda H;
    Ann Thorac Surg; 2002 Dec; 74(6):1953-7. PubMed ID: 12643379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of patients with completely resected lung cancer.
    Downey RJ
    Chest; 1999 Jun; 115(6):1487-8. PubMed ID: 10378535
    [No Abstract]   [Full Text] [Related]  

  • 8. Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer.
    Westeel V; Choma D; Clément F; Woronoff-Lemsi MC; Pugin JF; Dubiez A; Depierre A
    Ann Thorac Surg; 2000 Oct; 70(4):1185-90. PubMed ID: 11081867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invited Commentary.
    Shrager J
    Ann Thorac Surg; 2016 Jun; 101(6):2146-7. PubMed ID: 27211933
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical implication of pulmonary excision for undiagnosed peripheral lung cancer.
    Funakoshi Y; Sawabata N; Takeuchi Y; Kusumoto H; Kimura T; Maeda H
    Interact Cardiovasc Thorac Surg; 2011 Nov; 13(5):485-9. PubMed ID: 21835845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "cured" lung cancer patient: is follow-up by the surgeon worthwhile?
    Hiebert CA
    Ann Thorac Surg; 1995 Dec; 60(6):1557-8. PubMed ID: 8787442
    [No Abstract]   [Full Text] [Related]  

  • 12. Density of tumor-infiltrating lymphocytes correlates with disease recurrence and survival in patients with large non-small-cell lung cancer tumors.
    Kilic A; Landreneau RJ; Luketich JD; Pennathur A; Schuchert MJ
    J Surg Res; 2011 May; 167(2):207-10. PubMed ID: 19896677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local treatment of oligometastatic recurrence in patients with resected non-small cell lung cancer.
    Yano T; Okamoto T; Haro A; Fukuyama S; Yoshida T; Kohno M; Maehara Y
    Lung Cancer; 2013 Dec; 82(3):431-5. PubMed ID: 24113550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence pattern and rapid intraoperative detection of carcinoembryonic antigen (CEA) mRNA in pleural lavage in patients with non-small cell lung cancer (NSCLC).
    Sugai S; Satoh Y; Komatsu M; Okumura S; Nakagawa K; Ishikawa Y; Miki Y
    Rinsho Byori; 2008 Oct; 56(10):851-7. PubMed ID: 19068780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Pleural Lavage Cytology Both Before and After Lung Resection on Recurrence of Non-Small Cell Lung Cancer.
    Shoji F; Yamazaki K; Kouso H; Mori R; Takeo S
    Ann Thorac Surg; 2016 Jun; 101(6):2141-6. PubMed ID: 27012585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in surgical techniques in non-small cell lung cancer.
    Kim AW; Detterbeck FC
    Semin Respir Crit Care Med; 2013 Dec; 34(6):855-66. PubMed ID: 24258575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal predictive value of preoperative serum carcinoembryonic antigen for surgical outcomes in stage I non-small cell lung cancer: differences according to histology and smoking status.
    Kato T; Ishikawa K; Aragaki M; Sato M; Okamoto K; Ishibashi T; Oba K; Kaji M
    J Surg Oncol; 2013 May; 107(6):619-24. PubMed ID: 23192365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A Case of Slowly Progressive Brain Metastasis with Minor Bleeding after Removal of and Chemotherapy for Non-Small Cell Lung Cancer].
    Matsufuji H; Shiozaki E; Nakatake Y; Yoshida K; Kamada K; Matsuo T
    No Shinkei Geka; 2017 Apr; 45(4):339-344. PubMed ID: 28415059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma.
    Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
    Eur J Cardiothorac Surg; 2013 Sep; 44(3):e200-6. PubMed ID: 23766428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The prognostic impact of preoperative PET-CT on postoperative recurrence for completely resected stage I non-small cell lung cancer].
    Qiang G; Xu R; Liu J; Yan J; Xu Y; Di J; Da J; Liang C; Shi B; Guo Y; Liu D
    Zhonghua Wai Ke Za Zhi; 2015 Jul; 53(7):502-7. PubMed ID: 26359072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.